SLCO1B1 and myopathy: Meta‐analysis of the SLCO1B1 signal for rs4149056 limited to the simvastatin‐exposed cases and controls only (Figure2) led to a P value of 1.46 × 10−21 (OR 5.91; 95% CI 4.10–8.51; I2 = 1.00) for the severe myopathy phenotype and a P value of 2.01 × 10−14 (OR 2.75; 95% CI 2.12–3.56; I2 = 0.78) for the all myopathy phenotype.